The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)-Reference-Cited by-同舟云学术

The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)

Published:2015-11-20 Issue:4 Volume:122 Page:521-533
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

McMillan Matthew T.¹,Lewis Russell S.¹,Drebin Jeffrey A.¹,Teitelbaum Ursina R.²,Lee Major K.¹,Roses Robert E.¹,Fraker Douglas L.¹,Vollmer Charles M.¹

Affiliation:

1. Department of Surgery; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania

2. Division of Hematology/Oncology, Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology;Schmidt;Ann Surg,2007

2. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes;Mino-Kenudson;Gut,2011

3. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas;Distler;Ann Surg,2013

4. Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated carcinomas (≤20-mm invasive component): a multi-institutional analysis [published online ahead of print July 1, 2015];Winter;Ann Surg

5. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas;Poultsides;Ann Surg,2010

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study;Journal of Clinical Oncology;2024-09-10

2. Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study);Surgery;2024-09

3. Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy;Annals of Surgical Oncology;2024-07-03

4. Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre study;HPB;2024-07

5. Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study;British Journal of Surgery;2024-04